Sano Genetics
PrivateLast Round
VC Round
Jan 22, 2024
Total Funding Raised
$14.87M
Company Overview
Sano Genetics operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a VC Round in January 2024.
Sano Genetics is a biotechnology company that provides a platform to accelerate precision medicine research by integrating patient recruitment, genetic testing, and long-term participant engagement for clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Precision Medicine, Patient Engagement, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sano Genetics Comparables
Compare Sano Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trialbee | 83% | |
| Neuroute | 79% | |
| Antidote Technologies | 77% |
For institutional investors. Book with your work email.
Sano Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 22, 2024 | ||||
| Series A | Mar 28, 2022 | ||||
| Seed | Jan 26, 2021 | ||||
| Pre Seed | Apr 9, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sano Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Enterprise | Pre Seed, Seed |
| Plural | VC Round |
| January Ventures | Seed |
| Episode 1 | VC Round, Series A |
| MMC Ventures | VC Round, Series A |
| Episode 1 Ventures | VC Round, Series A, Seed |
| Seedcamp | VC Round, Pre Seed, Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2025
Added LearnFormula Inc., an EdTech startup, as a customer.
- Jan 22, 2024
$11.4M round closed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 27, 2026
Sano Genetics partners with Patients Know Best, Ltd. on contracted trial recruitment programmes.
For institutional investors. Book with your work email.
Sano Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sano Genetics's valuation, stock price, and market status.
Is Sano Genetics a public or private company?
Sano Genetics is a private company.
What is the current stock price of Sano Genetics?
Sano Genetics is a private company, so its shares have no public market price. Caplight tracks Sano Genetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sano Genetics worth (valuation)?
Valuation information for Sano Genetics is not publicly available.
Can I buy Sano Genetics stock?
Sano Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sano Genetics's last funding round?
Sano Genetics's most recent funding round was VC Round on January 22, 2024.
Who are the main investors in Sano Genetics?
Key investors in Sano Genetics include Plural, MMC Ventures, Episode 1 Ventures, Plural, Plural Platform.
Will Sano Genetics IPO soon?
No public IPO plans have been announced for Sano Genetics.
How can I track Sano Genetics secondary market activity?
Caplight tracks bids, offers, and trades in Sano Genetics's shares on secondary markets.